Screener
enGene Therapeutics Inc. ENGN Q3 2026 earnings
Reported September 8, 2026 · Before market open
EPS-$0.47Miss by $0.04
EPS estimate-$0.43
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did enGene Therapeutics Inc. report Q3 2026 earnings?
- enGene Therapeutics Inc. (ENGN) reported Q3 2026 earnings on September 8, 2026 before market open.
- What were enGene Therapeutics Inc.'s Q3 2026 revenue and EPS?
- enGene Therapeutics Inc. reported eps of $-0.47 for Q3 2026.
- Did enGene Therapeutics Inc. beat estimates in Q3 2026?
- EPS missed the consensus estimate of $-0.43 by $0.04.
- How did enGene Therapeutics Inc.'s Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 17.5% from $-0.57.
- Where can I find enGene Therapeutics Inc.'s Q3 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-384380) and the 10-Q periodic report (0001193125-26-384383) directly on SEC EDGAR. The filing index links above go to sec.gov.
